Cargando…

Actual Contribution of Free to Total PSA Ratio in Prostate Diseases Differentiation

OBJECTIVES: To determine significance and sensitivity of the Free to Total prostate specific antigen (PSA) ratio (%fPSA) in diagnosis of prostate cancer and to correlate its sensitivity and specificity with diagnosis. METHODS: Research included 220 patients, who had indication for biopsy (Clinic for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prcic, Alden, Begic, Edin, Hiros, Mustafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AVICENA, d.o.o., Sarajevo 2016
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034994/ https://www.ncbi.nlm.nih.gov/pubmed/27703291 http://dx.doi.org/10.5455/medarh.2016.70.288-292

Ejemplares similares

Usefulness of Total PSA Value in Prostate Diseases Diagnosis
por: Prcic, Alden, et al.
Publicado: (2016)

Complications After Ileal Urinary Derivations
por: Prcic, Alden, et al.
Publicado: (2017)

Variations in Nitric Oxide and Endothelin Serum Levels in Extracorporeal Shock Wave Lithotripsy-Treated Patients
por: Milisic, Emir, et al.
Publicado: (2019)

Utility of Free/Total Prostate Specific Antigen (f/t PSA) Ratio in Diagnosis of Prostate Carcinoma
por: Thakur, V., et al.
Publicado: (2004)

The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions
por: Flores-Fraile, María-Carmen, et al.
Publicado: (2020)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
por: Strittmatter, F, et al.
Publicado: (2011)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
por: LIU, Xin, et al.
Publicado: (2015)

The Actual (Un)usefulness of the Bologna System in Medical Education
por: Masic, Izet, et al.
Publicado: (2016)

The Relationship between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy
por: Duran, Mesut Berkan, et al.
Publicado: (2020)

Detection of Prostatic Inflammation From Peripheral Lymphocyte Count and Free/Total PSA Ratio in Men With LUTS/BPH
por: Liao, Xinyang, et al.
Publicado: (2020)

Clinical Significance of Free-to-Total Prostate-Specific Antigen (PSA) Ratio in Advanced Prostate Cancer Patients with PSA Less than 0.1 ng/ml after Hormone Treatment
por: Kim, Dae Il, et al.
Publicado: (2012)

Serum Aldosterone as Predictor of Progression of Coronary Heart Disease in Patients Without Signs of Heart Failure After Acute Myocardial Infarction
por: Resic, Nerma, et al.
Publicado: (2018)

Preoperative Kidney Tumor Embolization as Procedure for Therapy of Advanced Kidney Cancer
por: Jaganjac, Suad, et al.
Publicado: (2014)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men
por: Murray, Nigel P., et al.
Publicado: (2014)

The Significance of PSA/IGF-1 Ratio in Differentiating Benign Prostate Hyperplasia from Prostate Cancer
por: Koliakos, G., et al.
Publicado: (2000)

Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0–25.0 ng ml(-1) in Western China
por: Gao, Xue-Dan, et al.
Publicado: (2021)

Free PSA performs better than total PSA in predicting prostate volume in Chinese men with PSA levels of 2.5–9.9 ng ml(−1)
por: Huang, Ma-Ping, et al.
Publicado: (2022)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
por: Jung, Jin-Woo, et al.
Publicado: (2019)

Significance of PSA Screening in Niigata, Japan: Survey of Actual Status of New Cases of Prostate Cancer
por: Saito, Toshihiro, et al.
Publicado: (2021)

Evaluation of Diagnostic Methods in the Differentiation of Heart Murmurs in Children
por: Begic, Zijo, et al.
Publicado: (2016)

A Neural Network Model Combining [-2]proPSA, freePSA, Total PSA, Cathepsin D, and Thrombospondin-1 Showed Increased Accuracy in the Identification of Clinically Significant Prostate Cancer
por: Gentile, Francesco, et al.
Publicado: (2023)

Value of free/total prostate-specific antigen (f/t PSA) ratios for prostate cancer detection in patients with total serum prostate-specific antigen between 4 and 10 ng/mL: A meta-analysis
por: Huang, Yan, et al.
Publicado: (2018)

DOES THE COMBINATION OF INTRAVESICAL PROSTATIC PROTRUSION AND BLADDER OUTLET OBSTRUCTION NUMBER INCREASE TEST ACCURACY ACCORDING TO BENIGN PROSTATIC OBSTRUCTION AT THE INDIVIDUAL LEVEL?
por: Aganovic, Damir, et al.
Publicado: (2012)

Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer
por: Chavan, Sushant V., et al.
Publicado: (2014)

The value of percentage free prostate specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria
por: Ezenwa, E.V., et al.
Publicado: (2012)

Serum Fucosylated Prostate-specific Antigen (PSA) Improves the Differentiation of Aggressive from Non-aggressive Prostate Cancers
por: Li, Qing Kay, et al.
Publicado: (2015)

USE AND KNOWLEDGE ON THE INFORMATION TECHNOLOGIES IN MEDICAL EDUCATION -BOSNIAN AND HERZEGOVINIAN EXPERIENCE
por: Masic, Izet, et al.
Publicado: (2016)

Sickness Impact Profile (SIP) Score, a Good Alternative Instrument for Measuring Quality of Life in Patients with Ileal Urinary Diversions
por: Prcic, Alden, et al.
Publicado: (2013)

Impact of Complications and Bladder Cancer Stage on Quality of Life in Patients with Different Types of Urinary Diversions
por: Prcic, Alden, et al.
Publicado: (2013)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

Information Technology – a Tool for Development of the Teaching Process at the Faculty of Medicine, University of Sarajevo
por: Masic, Izet, et al.
Publicado: (2015)

Meta-analysis as Statistical and Analytical Method of Journal’s Content Scientific Evaluation
por: Masic, Izet, et al.
Publicado: (2015)

Biomedical Scientific and Professional Social Networks in the Service of the Development of Modern Scientific Publishing
por: Masic, Izet, et al.
Publicado: (2016)

The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy
por: Huskova, Zlata, et al.
Publicado: (2020)

Evaluation of the Occlusive Arterial Disease and Diabetic Angiopathy Treatment Effects by Hyperbaric Oxygenation
por: Begić, Alden, et al.
Publicado: (2019)

Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate
por: Agnihotri, Shalini, et al.
Publicado: (2014)

Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4–10 ng ml(−1)
por: Tan, Lincoln GL, et al.
Publicado: (2017)

Prostate-specific antigen kinetics contributes to decision making for biopsy referral: the predictive implication for PSA retest in patients with elevated PSA levels
por: Kobayashi, Minoru, et al.
Publicado: (2023)

Editorial comment to “The value of percentage free prostate-specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria” and Reply by authors
por: Elabbady, Ahmed, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7t6de1tq1mljknqnpsktjf25ps